5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma

Caroline Robert, Jacob Schachter, Georgina V. Long, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S. Carlino, Catriona McNeil, Michal Lotem, James Larkin, Paul Lorigan, Bart Neyns, Christian U. Blank, Omid Hamid, Teresa M. Petrella, James Anderson, Clemens Krepler, Scott J. Diede, Antoni Ribas

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
JournalCancer Research
Volume79
Issue number13
DOIs
Publication statusPublished - Jul 2019

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this